Baxter International Inc.
BAX Healthcare Medical Instruments & Supplies
Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.
- Revenue
- +4.97%
- EPS
- +731.9%
- Free cash flow
- +255.6%
- Total debt
- −9.48%
Quarter to September 2026, against a year earlier
Follow BAX
Alert me
Baxter International Inc. (BAX) Current ratio
Baxter International Inc.'s current ratio at the end of the quarter to 30 September 2026 was 1.8×, down 0.5× from fiscal 2025 (2.3×). Over the past ten years it has ranged from 1.4× (fiscal 2024) to 2.6× (fiscal 2017); the current reading is higher than 64% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 2.3× | 70.17% |
| FY2024 | 1.4× | (7.89%) |
| FY2023 | 1.5× | (12.56%) |
| FY2022 | 1.7× | (19.39%) |
| FY2021 | 2.1× | (17.01%) |
| FY2020 | 2.5× | 8.64% |
| FY2019 | 2.3× | 9.69% |
| FY2018 | 2.1× | (17.75%) |
| FY2017 | 2.6× | 7.46% |
| FY2016 | 2.4× | 16.78% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.8× | (7.92%) |
| Jun 2026 | 1.9× | 4.98% |
| Mar 2026 | 1.9× | (19.87%) |
| Dec 2025 | 2.3× | 25.98% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| RGEN Repligen Corporation compare | 9.9× |
| WST West Pharmaceutical Services, Inc. compare | 2.8× |
| AVTR Avantor, Inc. compare | 1.9× |
| BAX Baxter International Inc. | 1.8× |
| BLCO Bausch + Lomb Corporation compare | 1.6× |
| ATR AptarGroup, Inc. compare | 1.5× |
| ALGN Align Technology, Inc. compare | 1.4× |
| COO The Cooper Companies, Inc. compare | 1.2× |
| SOLV Solventum Corporation compare | 1.0× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on BAX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement